Collaborations & Alliances

AbbVie, Calico Extend R&D Alliance

Each company will commit to contribute an additional $500 million to the collaboration

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie and Calico have extended their collaboration to discover, develop and market new therapies for patients with age-related diseases, including neurodegeneration and cancer.    Calico is the Alphabet-backed life sciences company that is led by former Genentech chairman and chief executive officer Arthur D. Levinson, Ph.D.  Calico has a research and development facility in the San Francisco Bay Area and more than 150 employees.     The collaboration has been extended for an additional thr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters